Quince Therapeutics (QNCX) Ending Cash Balance (2018 - 2026)
IRulya Therapeutics (QNCX) recorded Ending Cash Balance of $115.98 million in Q2 2026, up 589.3% from $16.83 million a year earlier and up 538.6% from the prior quarter.
Powered by 
Analysis
Quince Therapeutics (QNCX) Ending Cash Balance (2018 - 2026) Analysis & Trends
For FY2025, IRulya Therapeutics reported Ending Cash Balance of $5.81 million, down 6.5% from FY2024.
- Annual Ending Cash Balance has declined for three straight years, with a three-year compound annual growth rate of -49.3% (FY2022 to FY2025).
- Across earlier years, Ending Cash Balance came in at $6.21 million in FY2024 (-70.1%), $20.75 million in FY2023 (-53.4%) and $44.58 million in FY2022.
- The Q2 2026 figure is the highest quarterly Ending Cash Balance in data going back to Q4 2018.
- On a year-over-year basis, Ending Cash Balance rose in four of the last eight quarters, with growth averaging 93.6%.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 589.3% in Q2 2026, against a decline of 87.6% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $18.16 million (Q1 2026), $5.81 million (Q4 2025) and $6.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.88 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 1.03 Bn |
| 10 | IRulya Therapeutics | 201.34 Mn | 229.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115.98 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 5.81 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Jun 30, 2025 | 16.83 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 21.81 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 21.63 Mn |
| Jun 30, 2023 | 22.65 Mn |
| Dec 31, 2022 | 44.58 Mn |
| Dec 31, 2019 | 51.21 Mn |
| Dec 31, 2018 | 24.87 Mn |
API Access
Quince Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=QNCX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "QNCX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=QNCX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();